Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer

Tremendous progress has been achieved in the field of immune checkpoint inhibitors (ICIs) therapy in lung cancer in recent years. To generate robust, long-lasting anti-tumor immune responses in lung cancer patients, combinational ICI therapies have been explored deeply. Conventionally, chemotherapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Liu, Wei, Zhang, Lei, Xiu, Zhiming, Guo, Jian, Wang, Liye, Zhou, Yue, Jiao, Yang, Sun, Meiyan, Cai, Jianhui
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7394580/
https://ncbi.nlm.nih.gov/pubmed/32801752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S255491
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados